NEW YORK (GenomeWeb) – Startup drug discovery firm Verge Genomics today announced it has raised $4 million in seed funding.

IA Ventures led the round, joined by Two Sigma Ventures, Draper Associates, Great Oaks VC, Slow Ventures, Karlin Ventures, and other private investors. San Francisco-based Verge came out of the Y Combinator accelerator and is also a spinout of the University of California, Los Angeles.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.